PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 2005Journal of Clinical Investigation884 citationsOpen Access

IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy

JLJun‐Li Luo

Key Points

Key points are not available for this paper at this time.

Abstract

IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling pathways play critical roles in a variety of physiological and pathological processes. One function of NF-kappaB is promotion of cell survival through induction of target genes, whose products inhibit components of the apoptotic machinery in normal and cancerous cells. NF-kappaB can also prevent programmed necrosis by inducing genes encoding antioxidant proteins. Regardless of mechanism, many cancer cells, of either epithelial or hematopoietic origin, use NF-kappaB to achieve resistance to anticancer drugs, radiation, and death cytokines. Hence, inhibition of IKK-driven NF-kappaB activation offers a strategy for treatment of different malignancies and can convert inflammation-induced tumor growth to inflammation-induced tumor regression.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jun‐Li Luo (2005) studied this question.

synapsesocial.com/papers/69ffab79e4618ba4162d8a36https://doi.org/10.1172/jci26322
Ask AI
Helpful
Bookmark
Share
View Full Paper